Metronomic capecitabine plus AI significantly improved PFS and OS in HR-positive, HER2-negative metastatic breast cancer compared to AI alone. The MECCA trial enrolled 263 patients, with balanced ...
March 1, 2012 — The anti-inflammatory drug celecoxib (Celebrex, Pfizer) can be used to significantly reduce hand-foot syndrome (HFS), the most common adverse effect of an increasingly popular ...
Detailed price information for Processa Pharmaceuticals Inc (PCSA-Q) from The Globe and Mail including charting and trades.
Trastuzumab-Pertuzumab Plus Eribulin or Taxane as First-Line Chemotherapy for Human Epidermal Growth Factor 2–Positive Locally Advanced/Metastatic Breast Cancer: The Randomized Noninferiority Phase ...
Patients with HER2-positive metastatic breast cancer may consider related side effects and quality of life outcomes when choosing treatments. Patients receiving Enhertu (fam-trastuzumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback